Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Cryptos Muted As U.S. CPI Fails To Slide As Expected
  2. Bowlero Corp. Slips 8% Following Q1 Results
  3. Bitcoin ($BTC) Price Mirroring Previous Bottom Formations, Says Popular Crypto Analyst
  4. Analyst PlanB On How Current BTC HODLers Will Lay the Foundation for The Next Bitcoin Bull Run
  5. Cryptos Surge Ahead Amidst ETF Frenzy, Bitcoin Jumps Above $28k